| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
and pS2 Gene Expression in Breast Carcinoma Cells1
Department of Medicine, University of Maryland Cancer Center, and Veterans Administration Medical Center, Baltimore, Maryland 21218 [J. A. F., Z-M. S.], and Cell Biology Section, Laboratory of Pulmonary Pathobiology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [C. N., A. M. J.]
Exposure of MCF-7 breast carcinoma cells to estradiol results in an increase in transforming growth factor
(TGF-
) synthesis and secretion. Since TGF-
is a potent inducer of proliferation in MCF-7 cells, the increase in TGF-
production by estradiol is thought to play an important role in the estrogen stimulation of growth of these cells. Retinoic acid inhibits the proliferation of MCF-7 cells and antagonizes the estrogen stimulation of growth. Addition of retinoic acid resulted in a greater than 70% inhibition of estradiol-induced TGF-
synthesis and secretion in MCF-7 cells. The increase in TGF-
mRNA expression by estradiol was also inhibited by exposure of the cells to retinoic acid. Pretreatment of the cells with retinoic acid for 24 or 72 h caused more than 50 and 90% inhibition, respectively, of the estradiol-enhanced expression of TGF-
mRNA. Expression of pS2 mRNA in MCF-7 cells was stimulated approximately 8-fold by estradiol. Retinoic acid treatment suppressed by greater than 80% both the basal and estradiol-induced pS2 mRNA expression. Retinoic acid modulation of the estrogen receptor gene mRNA was not responsible for the retinoic acid inhibition of the stimulation of pS2 and TGF-
gene expression by estradiol, since estrogen receptor gene expression was increased rather than decreased in the presence of retinoic acid. The nuclear retinoic acid receptors
and
mRNA were expressed in MCF-7 cells and its retinoic acid-resistant derivative RROI. Addition of estradiol to MCF-7 cells resulted in a decreased expression of retinoic acid receptor
mRNA; this reduction is prevented by the presence of retinoic acid.
These results indicate that retinoic acid can inhibit estradiol-induced TGF-
and pS2 mRNA expression in MCF-7 cells. The suppression of TGF-
expression may represent one possible mechanism by which retinoic acid antagonizes the stimulation of MCF-7 proliferation by estradiol.
1 This work was partly supported by the Veterans Administration.
2 To whom requests for reprints should be addressed, at University of Maryland at Baltimore, Cancer Center, Room S9D05, 22 S. Greene Street, Baltimore, MD 21201.
Received 12/18/91. Accepted 5/ 7/92.
This article has been cited by other articles:
![]() |
J. Laganiere, G. Deblois, and V. Giguere Functional Genomics Identifies a Mechanism for Estrogen Activation of the Retinoic Acid Receptor {alpha}1 Gene in Breast Cancer Cells Mol. Endocrinol., June 1, 2005; 19(6): 1584 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. White, M. M. Yore, D. Deng, and M. J. Spinella Limiting Effects of RIP140 in Estrogen Signaling: POTENTIAL MEDIATION OF ANTI-ESTROGENIC EFFECTS OF RETINOIC ACID J. Biol. Chem., March 4, 2005; 280(9): 7829 - 7835. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rousseau, J. N. Nichol, F. Pettersson, M.-C. Couture, and W. H. Miller Jr. ER{beta} Sensitizes Breast Cancer Cells to Retinoic Acid: Evidence of Transcriptional Crosstalk Mol. Cancer Res., September 1, 2004; 2(9): 523 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Quaia, P. Zancai, R. Cariati, S. Rizzo, M. Boiocchi, and R. Dolcetti Glucocorticoids promote the proliferation and antagonize the retinoic acid-mediated growth suppression of Epstein-Barr virus-immortalized B lymphocytes Blood, July 15, 2000; 96(2): 711 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Favoni and A. De Cupis The Role of Polypeptide Growth Factors in Human Carcinomas: New Targets for a Novel Pharmacological Approach Pharmacol. Rev., June 1, 2000; 52(2): 179 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sun, W. Porter, and S. Safe Estrogen-Induced Retinoic Acid Receptor {alpha}1 Gene Expression: Role of Estrogen Receptor-Sp1 Complex Mol. Endocrinol., June 1, 1998; 12(6): 882 - 890. [Abstract] [Full Text] |
||||
![]() |
C. Teixeira and M. A. C. Pratt CDK2 Is a Target for Retinoic Acid-Mediated Growth Inhibition in MCF-7 Human Breast Cancer Cells Mol. Endocrinol., August 1, 1997; 11(9): 1191 - 1202. [Abstract] [Full Text] |
||||
![]() |
M. A.C. Pratt, D. Deonarine, C. Teixeira, D. Novosad, B. F. Tate, and J. F. Grippo The AF-2 Region of the Retinoic Acid Receptor alpha Mediates Retinoic Acid Inhibition of Estrogen Receptor Function in Breast Cancer Cells J. Biol. Chem., August 23, 1996; 271(34): 20346 - 20352. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kolla, D. J. Lindner, X. Weihua, E. C. Borden, and D. V. Kalvakolanu Modulation of Interferon (IFN)-inducible Gene Expression by Retinoic Acid J. Biol. Chem., May 3, 1996; 271(18): 10508 - 10514. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lessard, C. Zhao, S. M. Singh, and R. Poulin Hormonal and Feedback Regulation of Putrescine and Spermidine Transport in Human Breast Cancer Cells J. Biol. Chem., January 27, 1995; 270(4): 1685 - 1694. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |